Education
About Us
Working with TipRanks
Follow Us
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
Earnings Data
Report Date
Mar 25, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.1Last Year’s EPS
-0.11Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call was largely positive, with Trevi Therapeutics reporting successful trial data, financial stability, and strategic plans to expand their market opportunities. Although there were some financial losses and regulatory challenges, the company's advancements and cash reserves suggest a promising outlook.Company Guidance
Successful Data Readouts and Funding
Trevi Therapeutics reported positive data readouts from the CORAL trial for chronic cough in IPF patients and the RIVER trial for refractory chronic cough. They raised approximately $100 million in June, providing cash runway into 2028.
Progress in Clinical Trials
Trevi has completed important Phase I studies for their IPF cough program and received no clinically meaningful changes in drug interactions. They also reported no safety signals in a sentinel cohort of their TITLE study.
Financial Stability
As of September 30, 2025, Trevi's cash and investments totaled approximately $195 million, sufficient to fund multiple Phase III trials and ongoing studies.
Market Expansion Opportunities
Trevi plans to initiate studies in non-IPF ILD, potentially doubling the market opportunity for their chronic cough treatments.
TRVI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TRVI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | $11.46 | $11.37 | -0.79% |
Aug 07, 2025 | $7.30 | $7.42 | +1.64% |
May 08, 2025 | $6.60 | $6.60 | 0.00% |
Mar 18, 2025 | $6.56 | $6.81 | +3.81% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Trevi Therapeutics Inc (TRVI) report earnings?
Trevi Therapeutics Inc (TRVI) is schdueled to report earning on Mar 25, 2026, After Close (Confirmed).
What is Trevi Therapeutics Inc (TRVI) earnings time?
Trevi Therapeutics Inc (TRVI) earnings time is at Mar 25, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TRVI EPS forecast?
TRVI EPS forecast for the fiscal quarter 2025 (Q4) is -0.1.